|
HS Code |
790937 |
| Product Name | Pig Bone Chondroitin Sulfate |
| Source | Pig bone |
| Appearance | White to off-white powder |
| Purity | ≥90% |
| Solubility | Soluble in water |
| Molecular Weight | 10,000-50,000 Da |
| Cas Number | 9007-28-7 |
| Odor | Odorless |
| Moisture Content | ≤10% |
| Storage Conditions | Cool, dry place |
| Shelf Life | 2 years |
| Assay Method | UV spectrophotometry |
| Intended Use | Nutritional supplements |
| Allergen Status | Contains animal origin |
As an accredited Pig Bone Chondroitin Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Pig Bone Chondroitin Sulfate features a sealed 1kg white plastic bag, labeled with product details, origin, and batch number. |
| Shipping | Pig Bone Chondroitin Sulfate is shipped in sealed, moisture-proof, and food-grade packaging to ensure product integrity and safety. It is transported in cool, dry conditions, with clear labeling for handling and storage. Standard shipping includes documentation such as SDS, COA, and compliance with relevant chemical and safety regulations. |
| Storage | Pig Bone Chondroitin Sulfate should be stored in a cool, dry, and well-ventilated area away from direct sunlight and moisture. Keep the container tightly closed to prevent contamination and degradation. Ideally, store at room temperature (15-25°C) and avoid exposure to heat, strong acids, or oxidizing agents. Ensure storage in a labeled, original packaging for safety and identification. |
| Purity 98%: Pig Bone Chondroitin Sulfate with 98% purity is used in pharmaceutical tablet formulations, where enhanced bioavailability and efficacy are achieved. Molecular Weight 25 kDa: Pig Bone Chondroitin Sulfate with a molecular weight of 25 kDa is used in joint health supplements, where optimal absorption and cartilage support are ensured. Viscosity Grade 120 mPa·s: Pig Bone Chondroitin Sulfate with viscosity grade of 120 mPa·s is used in ophthalmic solutions, where improved lubricity and stability are provided. Particle Size <100 μm: Pig Bone Chondroitin Sulfate with particle size less than 100 μm is used in cosmetic creams, where better skin penetration and smooth texture are delivered. Stability Temperature up to 60°C: Pig Bone Chondroitin Sulfate with stability temperature up to 60°C is used in functional food fortification, where ingredient integrity is maintained during processing. Sulfation Level 1.2:1 Ratio: Pig Bone Chondroitin Sulfate with a sulfation level of 1.2:1 ratio is used in nutraceutical beverages, where high bioactivity and solubility are promoted. Ash Content ≤8%: Pig Bone Chondroitin Sulfate with ash content not exceeding 8% is used in injectable formulations, where purity and safety standards are met. Endotoxin Level <0.5 EU/mg: Pig Bone Chondroitin Sulfate with endotoxin level under 0.5 EU/mg is used in medical device coatings, where reduced inflammatory response is achieved. Moisture Content ≤10%: Pig Bone Chondroitin Sulfate with moisture content at or below 10% is used in powder blends for dietary supplements, where improved shelf life and flowability are ensured. Heavy Metal Content <10 ppm: Pig Bone Chondroitin Sulfate with heavy metal content less than 10 ppm is used in veterinary formulations, where compliance with safety standards is maintained. |
Competitive Pig Bone Chondroitin Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Decades in the chemical industry have left our hands stained with the unmistakable work of turning raw animal materials into products that matter. Pig bone chondroitin sulfate, pulled from the dense, mineral-rich bones of pigs, isn’t just another off-the-shelf additive. Producing this compound takes careful attention all the way from knuckle to final powder, and it’s a process built on practical know-how and solid science.
Raw pig bones show up at our doors by the ton, fresh from approved slaughterhouses committed to both animal welfare and traceability. Every day, our manufacturing crew separates, cleans, and chops these bones to a consistent size, streamlining everything for extraction. Right away, the material swings into pre-extraction soaking tanks—not an afterthought, but an essential step: removing unwanted fats, proteins, and residual blood. Skipping this part only leads to product loaded with impurities, something no responsible maker will ship.
Clean bones move into controlled hydrolysis tanks. We use warm water and food-grade enzymes in a carefully tuned bath, breaking down cartilage and connective tissue. Years ago, we wrestled with traditional acid extraction methods, but enzyme processes leave more of the natural chondroitin structure intact. It also helps us sidestep the problem of harsh chemical residues ending up in the final product—something every manufacturer needs to answer for if they chase quantity over quality. Our team checks solution clarity, viscosity, and odor during extraction. Whenever something’s off, it doesn’t get swept under the rug or blended away; it gets fixed or rerun. That way, everything shipped off the line matches the standards laid out in our own internal protocol—not just the minimums set by pharmacopeia.
Our current batch, tagged under model CS-PB901, runs at a minimum purity of 90 percent by UV. Moisture sits below 9 percent. Protein, a key contaminant in poorly refined batches, tests in the low single digits. No visible residue or off-colors survive final filtration and purification. We check sulfation patterns using HPLC—a crucial step, since not all chondroitin sulfates are the same, and variation here changes both application performance and regulatory status worldwide. Finished product settles into free-flowing, off-white powder that dissolves with minimal agitation. Hydration characteristics and viscosity both reflect the natural mucopolysaccharide backbone—the hallmark of authentic chondroitin sulfate from pig bone, the right way.
Over the years, third-party labs and our end-users have both pressured us to keep levels of heavy metals such as lead, cadmium, and mercury far beneath legal limits. We respond with every clean-in-place, tested tank. Microbial risk gets knocked down with sterilized production spaces and ongoing monitoring. Salmonella and E. coli aren’t marketing problems—they’re business-ending failures in this world. Instead of rolling the dice, our crew tracks the source of every shipment and runs multiple spot checks on every shift. If there’s any sign an operator didn’t follow process, or a filtration unit underperformed, that entire run gets isolated and retested. These steps aren’t just for audits or sales brochures—they protect both us and the customer base built over years of steady supply.
Customers look to us for pig bone chondroitin sulfate for good reason. This ingredient brings a unique molecular profile compared to chondroitin extracted from bovine or shark sources. Most pharmaceutical and nutraceutical producers call for strict reproducibility batch after batch, and pig bone material demonstrates steady behavior during tableting, granulation, and blending. Solution clarity, viscosity, and solubility each play a part in the end product’s shelf stability and function. Because our material comes from pig bone, it holds up consistently when paired with glucosamine, MSM, and other actives in joint support formulations—something we’ve validated with both pilot-scale and full commercial-scale production for customers around the globe.
For some, animal traceability stands front and center. With pig bone as a raw material, we control inputs tightly and track all steps along the way. In markets where bovine spongiform encephalopathy (BSE) concerns turn up, manufacturers and consumers often favor pig bone-derived chondroitin as the safer substitute. Halal and kosher concerns often steer customers in other directions, but for sectors focused on strict origin documentation, pig bone offers a trusted path.
Direct experience makes the differences between pig bone, bovine, and shark cartilage all too clear. Each source brings strengths and limitations based on extraction difficulty, molecular balance, and regulatory use cases. Bovine cartilage used to dominate the chondroitin market, but its availability flexes with the beef industry’s ups and downs; disease outbreaks have knocked out entire supply chains overnight, leaving brands scrambling for alternatives. Shark cartilage sells with the allure of marine origin, but ethical and ecological pushback—combined with limited scalability—keeps supply tight and expensive.
Pig bone stands out for availability and price stability. Modern pork production systems, especially in Asia and Europe, turn out a steady supply of clean, traceable bone material—making processor scheduling easier and major shortages far less likely. Human health risks such as BSE or other transmissible spongiform encephalopathies remain nearly non-existent in pig sources, which magnets regulatory clearance for pharmaceutical and supplement-grade material in many countries.
From a technical matter, molecular weight distribution and sulfation pattern both influence chondroitin performance in final use. Pig bone chondroitin sulfate typically sits in a middle range for viscosity and solution clarity compared with the lighter shark and heavier bovine materials. In finished tablets or caplets, pig bone material compresses smoothly without the stickiness seen in some marine extracts. For our regular food and pharma partners, this means formulation adjustments happen less often and downstream processing equipment faces fewer fouling or cleaning issues. Smaller companies or custom supplement blenders get technical support from us based on real data from our runs—not just graphs or tables cut from a supplier’s handbook.
The faces behind each shift bring their own pride and skill to the floor. Most of the current process engineers and technicians grew up in factories before online certification replaced hands-on troubleshooting. When an extraction batch runs long or a filtration clog happens, these folks don’t reach for a ticket or form—they tackle the problem by hand, then document what changed. This means today’s chondroitin sulfate is a moving target for us: tighter filtration, more specific enzymatic steps, reduced downtime, and faster turnarounds from bone to powder.
We regularly hold direct talks with R&D partners who push for higher purity or specialized grades, like sodium-free chondroitin for salt-sensitive formulations. Past collaborations led us to tweak temperature profiles for better yield or sharpen our in-process monitoring. Each year, quality demands change—customers want higher traceability, suppliers face changing regulations, and new research shifts preferred sulfation ratios. By keeping close relationships with veterinary, medical, and supplement producers, we catch trends early and can trial small lots in a matter of weeks rather than months. This flexibility keeps us competitive against larger producers who can’t adapt as fast.
Standing on the manufacturing side means more responsibility than simply meeting specs. Our company maintains direct contracts with slaughterhouses and rendering plants to make sure animal by-products never go to waste—or to dubious buyers overseas. Turning bones into chondroitin sulfate recycles material and lowers the environmental impact compared with landfilling or incineration. Real producers pay attention to wastewater, energy, and emissions. For years, we invested in closed-loop water systems and spent solvent recovery. These choices show up both in environmental audits and local community relations.
Some customers raise questions about animal welfare, antibiotic use, and hormone residues. While rendering removes most potential carryover, we stay transparent. Each batch receives a full paperwork package detailing input sources, processing logs, and final QC. We get regular unannounced visits from both authorities and third-party auditors. Rather than scrambling to cover mistakes, we run open-door policies so anyone interested can trace back to the material’s origin—right down to the day it left the slaughter line.
Documentation and compliance don’t stop at certificates. Our regulatory experts track the latest rules from North America, Europe, and Asia-Pacific. Changes in import codes, allergen testing, or GMP standards go straight into our standard operation procedures. Export teams guide our product through customs with the right Material Safety Data Sheets and declarations—no last-minute errors or withheld shipments because of paperwork fumbles.
Life as the direct manufacturer means solutions fall squarely on our shoulders, especially in a market as unpredictable as animal by-products. Outbreaks, transport bans, or labor shortages all send shockwaves downstream—to supplement makers, finished food producers, and the end consumer. We steady supply by spreading sourcing across several regions and maintaining storage for both raw bones and processed semi-finished material. Long-term contracts with suppliers help, but our purchasing team still spends hours each week verifying incoming goods, cross-checking paperwork, and keeping up with supplier audits to avoid breakdowns. This attention to detail keeps supply problems low, even during tight years.
Shipping raw animal goods faces ever-changing paperwork and inspection standards. Over the years, we’ve adjusted labeling and traceability for each destination, investing in more robust IT tracking, and hiring staff trained in local regulations. While these requirements add cost, they keep shipments flowing without diversion or loss. We take particular care entering markets with strict animal origin rules, labeling, and residue detection—extra time up front saves big headaches later.
Innovation in the field doesn’t stop at meeting current demand. Pharmaceutical and nutraceutical industries constantly push for cleaner, more bioavailable, and more functionally active chondroitin. Our R&D team runs pilot studies on alternative enzymatic reactions to increase purity, change molecular weights, or improve solubility. We work with partners to adapt drying technologies that cut down on energy use and improve the powder’s physical flow. Upcoming generations of chondroitin sulfate will likely look different: nano-milled, crystallized, or cross-linked for specific end-use within medical devices or new delivery systems.
For now, customer needs revolve around stable, safe, traceable product. Every kilo shipped leaves a paper and electronic trail from bone to final lot—customers claim this shortens their own accreditation timelines and boosts their confidence selling downstream. We also work hand-in-hand with research hospitals and clinical testing centers, contributing product for preclinical work that tracks safety and therapeutic activity. Results roll back into process improvements, sometimes shifting our own views of what counts as a top-tier product. This gives us an unusual relationship with the science behind chondroitin, since we see real-world data before it passes through marketing teams or sales-driven interpretation.
Many of the challenges faced by customers—variability, traceability, compliance—mirror our own pain points. Constant feedback channels with formulation scientists, process engineers, and regulatory staff keep all parties on the same page. When a batch underperforms, end-users alert us quickly, usually long before formal testing flags an issue. We pull retains, reanalyze, then share the findings openly. Sometimes this leads to a root-cause fix in our line, sometimes it means adjusting customer process or specs.
Process improvements rarely mean big breakthroughs; more often, improvement comes from ten or twenty small tweaks each year. A tighter mesh on a filtration step, a new sensor on a drying chamber, quicker moisture checks—each adds up to steady, visible improvements in purity and consistency. Plant crews buy in because they see their own suggestions in action, and R&D staff follow test results every step of the way. Unplanned downtime gets logged and dissected, with findings posted for all shifts to review. This cutthroat focus on process reliability keeps product quality up and costs down, offering partners an edge when their own customers push for better performance and documentation.
Building trust isn’t about selling features or reciting standards. From our vantage as the original manufacturer, every shipment, every lot, every run links back to a specific set of people and decisions. We invite long-term partners to visit the lines, inspect the process, and audit document flow. Data isn’t a marketing point—it’s a tool shared between teams, updated in real time and reviewed at each turnover. Some customers push for more real-time data; we respond with digital dashboards and remote access to test results, so procurement and R&D can check stats before orders even ship.
Over the years, our practices have adapted to outside feedback and regulatory changes, but the underlying principle remains. Make something real, stand behind it, and improve out loud as mistakes and improvements both come to light. Pig bone chondroitin sulfate may start in low-value animal by-products, but through focused, hard-earned expertise, it becomes an integral part of thousands of formulations—each demanding its own level of quality, safety, and consistency. On this end of the industry, the real story isn’t just in the specification sheet; it’s in the hands and choices of everyone working the line.